Last reviewed · How we verify

NCT05282524: HATCH

Helping Adults Perform Transvaginal Exams Via Coaching at Home

Completed NA Last updated 6 March 2023
What this trial tests

NA trial testing Transvaginal ultrasound performed by a woman herself (with remote healthcare professional supervision) in Women's Health in 67 participants. Completed in 7 February 2023.

Timeline
23 March 2022
Primary endpoint
7 February 2023
7 February 2023

Quick facts

Lead sponsorTurtle Health, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment67
Start date23 March 2022
Primary completion7 February 2023
Estimated completion7 February 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Turtle Health, Inc.

Who can join

18 and older, female only, with Women's Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To train ultrasound technologists (equivalently called sonographers) in remote ultrasound guidance. To capture imaging of the gynecologic organs visible on home ultrasound and pertinent to clinical care, specifically the ovaries and uterus. To train the independent readers, both obstetricians \& gynecologists (OB/GYNs) and reproductive endocrinologists (REIs), who will evaluate home ultrasound images over time in subsequent clinical trials.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Women's Health

Currently open trials in the same condition.

Other Turtle Health, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05282524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing